Direkt zum Inhalt
Merck

Defining the Role of Mitochondrial Fission in Corneal Myofibroblast Differentiation.

Investigative ophthalmology & visual science (2022-04-05)
Kye-Im Jeon, Ankita Kumar, Kaitlin T Wozniak, Keith Nehrke, Krystel R Huxlin
ZUSAMMENFASSUNG

Fibrosis caused by corneal wounding can lead to scar formation, impairing vision. Although preventing fibroblast-to-myofibroblast differentiation has therapeutic potential, effective mechanisms for doing so remain elusive. Recent work shows that mitochondria contribute to differentiation in several tissues. Here, we tested the hypothesis that mitochondrial dynamics, and specifically fission, are key for transforming growth factor (TGF)-β1-induced corneal myofibroblast differentiation. Mitochondrial fission was inhibited pharmacologically in cultured primary cat corneal fibroblasts. We measured its impact on molecular markers of myofibroblast differentiation and assessed changes in mitochondrial morphology through fluorescence imaging. The phosphorylation status of established regulatory proteins, both of myofibroblast differentiation and mitochondrial fission, was assessed by Western analysis. Pharmacological inhibition of mitochondrial fission suppressed TGF-β1-induced increases in alpha-smooth muscle actin, collagen 1, and fibronectin expression, and prevented phosphorylation of c-Jun N-terminal kinase (JNK), but not small mothers against decapentaplegic 3, p38 mitogen-activated protein kinase (p38), extracellular signal-regulated kinase 1 (ERK1), or protein kinase B (AKT). TGF-β1 increased phosphorylation of dynamin-related protein 1 (DRP1), a mitochondrial fission regulator, and caused fragmentation of the mitochondrial network. Although inhibition of JNK, ERK1, or AKT prevented phosphorylation of DRP1, none sufficed to independently suppress TGF-β1-induced fragmentation. Mitochondrial dynamics play a key role in early corneal fibrogenesis, acting together with profibrotic signaling. This is consistent with mitochondria's role as signaling hubs that coordinate metabolic decision-making. This suggests a feed-forward cascade through which mitochondria, at least in part through fission, reinforce noncanonical TGF-β1 signaling to attain corneal myofibroblast differentiation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Antimycin A aus Streptomyces sp.
Sigma-Aldrich
2-Desoxy-D-Glucose, ≥98% (GC), crystalline
Sigma-Aldrich
Anti-Cholin-Acetyltransferase-Antikörper, Chemicon®, from goat
Sigma-Aldrich
Rotenon, ≥95%
Sigma-Aldrich
Carbonylcyanid-4-(trifluormethoxy)phenylhydrazon, ≥98% (TLC), powder
Sigma-Aldrich
Dorsomorphin, ≥98% (HPLC)
Sigma-Aldrich
Anti-vesikulärer Glutamattransporter 1-Antikörper, serum, Chemicon®
Sigma-Aldrich
Anti-Arrestin-C-Antikörper, Chemicon®, from rabbit
Sigma-Aldrich
U0126, CAS-Nr. 109511-58-2, Calbiochem, U0126, CAS 109511-58-2, is a potent and specific inhibitor of MEK1 (IC₅₀ = 72 nM) and MEK2 (IC₅₀ = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK.
Sigma-Aldrich
Mdivi-1, ≥98% (HPLC), powder
Sigma-Aldrich
Anti-Brn-3a-Antikörper, POU-Domäne, Protein, Klon 5A3.2, culture supernatant, clone 5A3.2, Chemicon®
Sigma-Aldrich
SB 203580, SB 203580, CAS 152121-47-6, is a highly specific, potent, cell-permeable, selective, reversible, and ATP-competitive inhibitor of p38 MAP kinase (IC₅₀ = 34 nM in vitro, 600 nM in cells).
Sigma-Aldrich
Anti-Mitofusin-2 (N-Terminal) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Collagenase aus Clostridium histolyticum, Sigma Blend Type L, ≤1.0 FALGPA units/mg solid
Sigma-Aldrich
LY 294002, InSolution, ≥98%, 10 mM, reversible and specific inhibitor of PI 3-kinase